2019 AVBCC Summit Agenda

AVBCC

October 16-17, 2019 | New York Athletic Club, New York, NY

The 2019 AVBCC Summit agenda is not available at this time.


Download 2018 Summit Agenda

2018 Summit Agenda

Day 1 – Tuesday, October 30, 2018

6:30 am – 7:30 am Conference Registration
6:30 am – 7:30 am Networking Breakfast
7:30 am Opening Remarks and Greeting
  • Burt Zweigenhaft, Co-Chair, AVBCC
  • Michael Kolodziej, Co-Chair, AVBCC
  • William McGivney, Co-Chair, AVBCC
  • Jayson Slotnik, Co-Chair, AVBCC
7:30 am – 8:30 am Keynote
8:30 am – 9:15 am Tomorrow’s Cancer Care: A Government Policy Perspective
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty:
    • Randy Burkholder, VP, Policy and Research, PhRMA
    • Crystal Kuntz, VP, Healthcare Policy and Research, Biotechnology Innovation Organization (BIO)
    • A. Mark Fendrick, MD, Director, Center for Value-Based Insurance Design, University of Michigan
9:15 am – 10:00 am Tomorrow’s Cancer Care: An Insurance Payer’s Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Steve Peskin, MD, MBA, FACP, Executive Medical Director, Population Health, Horizon BCBS
    • William (Bill) Winkenwerder, Jr, MD, Chairman, CitiusTech and former CEO, Highmark Health
10:00 am – 10:45 am Tomorrow’s Cancer Care: A Center of Excellence Perspective
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Al Benson III, MD, FACP, FASCO, Northwestern Medicine
    • Maurie Markman, MD, President, CTCA Medicine & Science
10:45 am – 11:15 am Tomorrow’s Cancer Care: The Community-Based Care Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Barry Brooks, MD, Medical Director, US Oncology
    • Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
    • Jeffrey Scott, MD, CMO, Integra Connect, LLC
11:15 am – 12:00 pm Keynote: Cancer Drug Trend Report
Doug Long, VP, Industry Relations, IQVIA
12:00 pm – 12:45 pm Keynote: Cancer Care into the Future
Greg Simon, President, Biden Cancer Initiative
12:45 pm – 1:30 pm
Tomorrow’s Cancer Care: The Employer Perspective
  • Moderator: F. Randy Vogenberg, PhD, RPh, Principal, Institute for Integrated Healthcare (IIH)
  • Faculty:
    • Michael Thompson, President & CEO, National Alliance of Healthcare Purchaser Coalitions
    • Patricia Goldsmith, CEO, CancerCare
Optimizing Patient Services: Solutions in Cancer Care
  • Moderator: Douglas Bock, Partner, Archbow Consulting
  • Faculty:
    • Sumner Madden, Senior Director, Access360, AstraZeneca
    • Michael Fitzgibbons, CEO, Claritas Rx
    • Tara Herington, RN, VP, Sonexus™ Access and Patient Support, Cardinal Health
1:30 pm – 2:15 pm Tomorrow’s Cancer Care: A Pharma Perspective
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline
    • Kim Blackwell, MD, VP, Early Phase Development & Immuno-oncology, Eli Lilly & Co
Track 1:
CLINICAL
Track 2:
TECHNOLOGY
Track 3:
SUPPLY CHAIN
Track 4:
BUSINESS
Track 5:
CONTRACTING
Track 6:
SPECIALTY PHARMACY
Track 7:
CARE MANAGEMENT
Track 8:
INDUSTRY SURVEY
2:15 pm – 3:15 pm
BREAKOUT 1: CLINICAL
Cell-Based Immunotherapies
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Alfred Slanetz, PhD, CEO, Genius Biotechnology
    • Kim Noonan, PhD, Founder & CSO, WindMIL Therapeutics
    • Sean Tunis, MD, MSc, Founder & CEO, Center for Medical Technology Policy
    • Kimberly Freeman, VP, Global Commercial Strategy, Adaptimmune
    • Greg Russotti, PhD, VP, Cell Therapy Technical Development, Celgene Corporation
BREAKOUT 2: TECHNOLOGY
Applying Machine Learning to Aid Decision-Making in Cancer Treatment
  • Moderator: Annatasiah Mhaka, PhD, Senior Advisor, Adjuvant Partners, and Co-Founder, Alliance for Artificial Intelligence In Healthcare
  • Faculty:
    • George Daneker, MD, CMO, Cancer Treatment Centers of America
    • William A. Flood, MD, MSc, CMO, eviti NantHealth
    • Robert S. Miller, MD, VP & Medical Director, CancerLinQ, American Society of Clinical Oncology
    • Rohit Borker, PhD, VP & Head, Health Economics and Outcomes Research, US Oncology: Novartis Pharmaceuticals Corporation
    • Ben Newton, PhD, Global Head, GE Healthcare Life Sciences Molecular Imaging
BREAKOUT 3: SUPPLY CHAIN
Oncology Supply Chain
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Randy Maloziec, VP, Bio Services, US Bioservices, an AmerisourceBergen Specialty Company
    • Lisa Harrison, Senior Director, Pharmacy and Clinical Services, ION Solutions
    • Nick Calla, RPh, Esq, VP, Industry Relations, Cardinal Health Specialty Solutions
BREAKOUT 4: CARE MANAGEMENT
The Patient Voice and Advocate Perspective
  • Moderator: Robert Goldberg, PhD, CEO, Thrive HealthRx
  • Faculty:
    • Daniel Klein, President & CEO, Patient Access Network Foundation
    • Clorinda Walley, CEO, Chronic Disease Fund
    • Patricia Goldsmith, CEO, CancerCare
    • Elizabeth Franklin, LGSW, ACSW, Executive Director, Cancer Policy Institute, Cancer Support Community
3:15 pm – 4:15 pm
BREAKOUT 5: SUPPLY CHAIN
CAR-T Pipeline and Market Access
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Amy DuRoss, MBA, Co-Founder & CEO, Vineti
    • Joel Brill, MD, CMO, Predictive Health, LLC
    • Bob Charles, BS, MBA, Founder/Principal The GeneriSys Company
    • Greta Stone, Deputy VP, Policy & Research, PhRMA
BREAKOUT 6: TECHNOLOGY
Big Data: “The New Oil”
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Marcus Neubauer, MD, VP & Medical Director, Value-Based Reimbursement, McKesson Specialty Health
    • Susan Weidner, MS, SVP, IntrinsiQ Specialty Solutions, AmerisourceBergen
    • Ash Malik, President, Life Sciences Division, Integra Connect, LLC
BREAKOUT 7: CONTRACTING
Update on the CMS Oncology Care Model and Other Oncology Alternative Payment Models
  • Moderator: Pamela Pelizzari, MPH, Healthcare Consultant, Milliman
  • Faculty:
    • Michael Ruiz de Somocurcio, MBA, VP, Payer & Provider Collaboration, Regional Cancer Care Associates
    • Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennsylvania State University
BREAKOUT 8: BUSINESS
The Burden of Cancer Care: Financial & Nonfinancial Costs Associated with Cancer Diagnosis & Treatment
  • Moderator: Christine Ferro, CHFP, Healthcare Analytics Consultant, Milliman
  • Faculty: Danielle Bubnis, Senior Director, Advocacy, Leukemia & Lymphoma Society
4:15 pm – 5:00 pm
BREAKOUT 9: CLINICAL
Genomics and Personalized Medicine
  • Moderator: Louis Jacques, MD, Chief Clinical Officer, ADVI Health LLC
  • Faculty:
    • Stan Skrzypczak, VP, Corporate Development & Reimbursement, Guardant Health
    • Edward Abrahams, PhD, President, Personalized Medicine Coalition
    • David Spetzler, MS, PhD, MBA, President & CSO, Caris Life Sciences
    • John Simmons, PhD, Director, Translational Science and Diagnostics, PGDx
    • Rachel Anhorn, PharmD, Director, Payer Policy and Health Outcomes, Foundation Medicine
BREAKOUT 10: CONTRACTING
Value-Based Oncology Care
  • Moderator: Jude Gallagher, PA, MBA, Former Director, Complex Clinical Care Strategy, Humana
  • Faculty:
    • Brian Bourbeau, MBA, LSSBB, Associate Director, Business Metrics and Analysis, American Society of Clinical Oncology (ASCO)
    • Virginia Calega, MD, MBA, FACP, VP, Medical Management & Policy, Independence Blue Cross
    • Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennsylvania State University
    • Ed Saltzman, Executive Chairman and Founder, Defined Health
BREAKOUT 11: TECHNOLOGY
Delivering Precision Medicine with New Digital Technologies
  • Moderator: Jeff Lombardo, PharmD, BCOP, Associate Director, Empire State Patient Safety Assurance Network
  • Faculty:
    • Andrew Norden, CMO, Cota Healthcare
    • Eric Sredzinski, EVP, Clinical and Quality Assurance, Avella Specialty Pharmacy
    • Scooter Plowman, MD, MBA, MHSA, Medical Director, Proteus Digital Health
BREAKOUT 12: SPECIALTY PHARMACY
A Vision for Pharma Value-Based Drug Contracting
  • Moderator: Tom Michaels, SVP, Sales, Vivaleas
  • Faculty:
    • Michael Reff, RPh, MBA, Executive Director & Founder, NCODA
    • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
    • Matt Farber, Senior Director, Patient Care & Advocacy, Oncology & Fertility, Walgreens
5:00 pm – 6:00 pm Keynote
  • Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator
  • Rob Butcher, Executive Director, Swim Across America
  • Steve Lundquist, 4-time Olympic Gold Medalist & World-Record Holder
Distinguished Researchers Panel:
  • Moderator: Neil Canavan, Author, A Cure Within
  • Panelists:
    • Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center
    • Luis Diaz, MD, Memorial Sloan Kettering Cancer Center
    • Axel Hoos, MD, President, Oncology, GlaxoSmithKline
6:00 pm – 9:00 pm

Evening Network Reception:
High-Value Auction Event to benefit Swim Across America: Making Waves to Fight Cancer

Book Signing: Neil Canavan, MSc, Author, A Cure Within

Day 2 – Wednesday, October 31, 2018

6:30 am – 7:00 am Networking Breakfast
7:00 am – 7:50 am Oncology Drug Pipeline Overview, Next 3 Years
  • Moderator: Jeffrey Bockman, PhD, EVP, Oncology Practice Head, Defined Health, a Cello Health business
  • Faculty:
    • Michael R. Mong, PharmD, Director, Specialty Pharmacy Development, Walgreen Co.
    • Cheryl Allen, BSPharm, MBA, VP, Industry Relations, Diplomat Pharmacy
7:50 am – 8:00 am Opening Remarks
Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 9:00 am Oncology Drug Benefits into the Future
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Everett Neville, RPh, EVP, Strategy, Supply Chain & Specialty, Express Scripts
    • Surya Singh, MD, Corporate VP, Head, Medical Benefit Management, CVS Caremark
    • Scott Reid, PharmD, eviCore Healthcare
    • C. Lyn Fitzgerald, SVP, US & Global Development, National Comprehensive Cancer Network
Track 1:
CLINICAL
Track 2:
TECHNOLOGY
Track 3:
SUPPLY CHAIN
Track 4:
BUSINESS
Track 5:
CONTRACTING
Track 6:
SPECIALTY PHARMACY
Track 7:
CARE MANAGEMENT
Track 8:
INDUSTRY SURVEY
9:00 am – 10:00 am
BREAKOUT 1: SUPPLY CHAIN
Strategies for Delivering on Pharmaceutical Value, a Focus on Quality
  • Moderator: Darin Rubin, CEO, Managing Director, The Dedham Group LLC
  • Faculty:
    • Danielle Ziernicki, BS, RPh, PharmD, National Quality Forum, Steering Committee for Cancer Project, The Dedham Group LLC
    • Ira Klein, MD, MBA, FACP, Senior Director, Healthcare Quality Strategy, J&J Health Care Systems
    • Norris Turner, PharmD, PhD, VP, Strategic Alliances and Measure Implementation, Pharmacy Quality Alliance
BREAKOUT 2: CLINICAL
Biosimilars and Impact on Cancer Care
  • Moderator: Robert Rifkin, MD, Medical Director, Biosimilars, US Oncology Network
  • Faculty:
    • William Yoon, PharmD, MBA, Executive Director & Head, US Medical Managed Markets & Strategic Alliances, Sandoz
    • John Kelton, PharmD, Biosimilars Medical Director, Pfizer
    • Chrys Kokino, Global Commercial Head, Biologics & Insulins, Mylan
    • Chad Pettit, Biosimilars Value and Access, Amgen
BREAKOUT 3: BUSINESS
The Pharma Food Chain—Driver of Inflation or Obstacle to Innovation?
  • Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman
  • Faculty:
    • Richard Evans, Founder and General Manager, SSR LLC
    • Brian DeBusk, CEO & President, DeRoyal; Vice Chair, Lincoln Memorial University; Commissioner, MedPAC
    • Anna Kaltenboeck, Program Director and Senior Health Economist, Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center
BREAKOUT 4: CARE MANAGEMENT
Standardized Measurements and Process for Navigating Cancer Care
  • Faculty:
    • Tricia Strusowski, MS, RN, Manager, Oncology Solutions; Chair, AONN+ Evidence into Practice Metrics Subcommittee
    • Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
10:00 am – 11:00 am
From K Street to Wall Street: A Look at Cancer Policy Influence on Markets
  • Moderator: Ipsita Smolinski, MBA, MPH, Managing Director, Capitol Street and McAllister & Quinn
  • Faculty:
    • Lisa Gill, Managing Director, Senior Analyst, Healthcare Technology & Distribution, JPMorgan Securities, Inc
    • PNC Bank (TBA)
    • Geoff Meacham, PhD, Managing Director, Biotech & Pharma Research, Barclays
Radiology
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Michael DeLeo, MD, Chief of Radiology, Southern New Hampshire Medical, Chair and Medical Director, Department of Radiology, Hampshire Medical
    • Raj Singla, MD, CMO, Radiation Therapy, eviCore Healthcare
    • Ilya Gipp, MD, PhD, Oncology Solutions Executive, Philips HealthTech
11:00 am – 12:00 pm
View from Capitol Hill and State Capitals: Public Policy Outlook for Cancer Care
  • Moderator: Lindsay Greenleaf, Director, ADVI Health LLC
  • Faculty:
    • John McManus, President & Founder, The McManus Group
    • Kavita Patel, MD, Brookings Institution
  • State panelists:
    • Anthony Fiori, Managing Director, Manatt Health
    • Kip Piper, MA, FACHE, President, Health Results Group, LLC
Oncology Nurse & Nurse Navigators: Best Kept Secret in Value-Based Care
  • Faculty:
    • Brenda Nevidjon, RN, MSN, FAAN, CEO, Oncology Nursing Society
    • Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
12:00 pm – 1:00 pm
Understanding Value Equations: Real-World Applications and Implications
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Peter Bach, MD, Director, Center for Health Policy & Outcomes, Memorial Sloan Kettering Cancer Center
    • Anthony V. Coletta, MD, MBA, EVP, and President, Facilitated Health Networks, Independence Health Group
    • Ravinder Dhawan, PhD, VP & Head, Oncology, Center for Observational & Real-World Evidence, Merck
    • Amy Niles, VP, External Relations, Pan Foundation
What Happens to a Cancer Patient, Stays with That Cancer Patient; When Will Physicians Accept Patient-Reported Data Into Their EMRs
  • Moderator: Rick Lee, MHA, Chairman, CancerLife
  • Faculty:
    • Charlie Coltman, Founder, CancerLife
    • Mark Soberman, MD, MBA, FACS, Chief Physician Executive, Monocacy Health Partners
    • Theresa Schmidt, MA, PMP, CSPO, Director, Discern Health
    • Gitesh Patel, Director, Global Business Development, Comprehensive Blood & Cancer Centers (CBCC)
1:00 pm – 2:00 pm
Clinical Decision Support in the Midst of Rapid Scientific Innovation
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health
    • Charles Saunders, CEO, Integra Connect
    • Marcus Neubauer, MD, VP, and Medical Director, Value-Based Reimbursement, McKesson Specialty Health
    • Atul Dhir, MD, DPhil, CEO, New Century Health
Patient Panel
  • Moderator: Jill Pollander, Director of Patient Services, National Organization for Rare Disorders
  • Faculty:
    • Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennslvania State University
    • Bob Tufts, Cancer Survivor and Professor, Yeshiva University
    • Matthew Zachery, CEO, Stupid Cancer
    • Jonny Imerman, Founder, Imerman Angels
2:00 pm – 2:45 pm Keynote
Clifford Hudis, MD, FACP, FASCO, CEO, American Society of Clinical Oncology
2:45 pm – 3:45 pm
BREAKOUT 5: TECHNOLOGY
Blockchain and Use Cases in Cancer Healthcare
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty:
    • Bob Charles, BS, MBA, The GeneriSys Company
    • Jennifer Hinkel, Partner, McGivney Global Advisors
BREAKOUT 6: SPECIALTY PHARMACY
Role of the Specialty Pharmacy in Cancer Care
  • Moderator: Sheila M. Arquette, RPH, Executive Director, National Association of Specialty Pharmacy
  • Faculty:
    • Paul Jardina, President & CEO, Onco360
    • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
    • Josh Stein, MBA, CEO, AdhereTech
    • Sheila Talty, RPh, MBA, Specialty Pharmacy, Business Development, Yale New Haven Health System
BREAKOUT 7: INDUSTRY SURVEY
Revitalizing Patient Cost-Sharing as a Benefit Control Tool: Results from an Industry Survey
  • Melinda Haren, RN, Senior Director, Access Strategies, Zitter Health Insights
BREAKOUT 8: BUSINESS
How Patient Support Services and Payer Policies Impact Patient Decision-Making, Adherence, and Treatment in Oncology
  • Moderator: Charles Stevens, Global Lead, ICON Access, Commercialisation & Communications/President MediMedia & Complete Healthcare Communications, ICONplc
  • Faculty:
    • Nicole Caswell, Executive Director of Operations, CoPilot Provider Services
    • Edward Hensley, Chief Commercial Officer & Co-Founder, AssistRx
    • Maggie Adamski, Senior Director, Patient Insights and Engagement, ICON
    • Douglas Bock, Partner, Archbow Consulting
3:45 pm – 4:30 pm Future Trends in the Cancer Care Ecosystem
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Brenton Fargnoli, MD, Medical Director, Flatiron Health
    • J. Lance Grady, VP Team Lead, Market Access & Reimbursement, Avalere Health
    • Bruce Gould, MD, Medical Director, Northwest Georgia Oncology Centers, P.C.
4:30 pm – 4:45 pm Closing Remarks

*Agenda is subject to change.

Return to Top